The Leeuwenhoek lecture, 1997: Marek's disease herpesvirus: Oncogenesis and prevention

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 352, Issue 1364, 1997, Pages 1951-1962

  Biggs, P M ^a  

^a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; AVES; GALLID HERPESVIRUS 2; GALLIFORMES; GALLUS GALLUS; HERPESVIRIDAE; HERPETOVIRUS; MARDIVIRUS;

EID: 0031590699     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.1997.0181     Document Type: Conference Paper

References (99)

1. Anderson, A. S., Francesconi, A. & Morgan, R. W. 1992 Complete nucleotide sequence of the Marek's disease virus ICP4 gene. Virology 189, 657-667.
2. Ball, R. F., Hill, J. F., Lyman, J. & Wyatt, A. 1971 The resistance to Marek's disease of chicks from immunized breeders. Poultry Sci. 50, 1084-1090.
3. Biggs, P. M. 1985 Spread of Marek's disease. In Marek's disease - scientific basis and methods of control (ed. L. N. Payne), pp. 329-340. Boston, MA: Martinus Nijhoff.
4. Biggs, P. M. & Milne, B. S. 1972 Biological properties of a number of Marek's disease virus isolates. In Oncogenesis and herpesviruses (ed. P. M. Biggs, G. de-Thé & L. N. Payne), pp. 88-94. Lyon: International Agency for Research on Cancer.
5. Biggs, P. M. & Payne, L. N. 1963 Transmission experiments with Marek's disease (fowl paralysis). Vet. Rec. 75, 177-179.
6. Biggs, P. M., Payne, L. N., Milne, B. S., Churchill, A. E., Chubb, R. C., Powell, D. G. & Harris, A. H. 1970 Field trials with an attenuated cell associated vaccine for Marek's disease. Vet. Rec. 87, 704-709.
7. Biggs, P. M., Powell, D. G., Churchill, A. E. & Chubb, R. C. 1972 The epizotiology of Marek's disease. I. Incidence of antibody, viraemia and Marek's disease in six flocks. Avion Path. 1, 5-25.
8. Biggs, P. M., Jackson, C. A. W. & Powell, D. G. 1973 The epizootiology of Marek's disease. II. The effect of supply flock, rearing house and production house on the incidence of Marek's disease. Avian Path. 2, 127-134.
9. Binns, M. M. & Ross, L. J. N. 1989 Nucleotide sequence of the Marek's disease virus (MDV) RB1B A antigen gene and the identification of the MDV A antigen as the herpes simplex virus-1 glycoprotein C homologue. Virus Res. 12, 371-382.
10. Bradley, G., Hayashi, M., Lancz, G., Tanaka, A. & Nonoyama, M. 1989a Structure of the Marek's disease virus BamH1-H gene family: genes of putative importance for tumor induction. J. Virol. 63, 2534-2542.
11. Bradley, G., Lancz, G., Tanaka, A. & Nonoyama, M. 1989b Loss of Marek's disease virus tumorigenicity is associated with truncation of RNAs transcribed within BamH1-H. J. Virol. 63, 4129-4135.
12. Brunovskis, P. & Velicer, L. F. 1992 Genetic organization of the Marek's disease virus unique short region and identification of Us encoded polypeptides. In Proc. 19th World's Poultry Cong., vol. 1, pp. 74-78. Wageningen: Ponsen & Looijen.
13. Brunovskis, P. & Velicer, L. F. 1995 The Marek's disease virus (MDV) unique short region: alphaherpesvirus-homologous, fowlpox virus-homologous, and MDV-specific genes. Virology 206, 324-338.
14. Brunovskis, P., Qian, Z., Li, D., Lee, L. F. & Kung, H.-S. 1996 Functional analysis of the MDV basic-leucine zipper product, MEQ. In Current research on Marek's disease: proc. 5th int. symp. on Marek's disease (ed. R. F. Silva, H. H. Chang, P. M. Coussens, L. F. Lee & L. F. Velicer), pp. 265-270. PA: American Association of Avian Pathologists.
15. Buckmaster, A. E., Scott, S. D., Sanderson, M. J., Boursnell, M. E. G., Ross, L. J. N. & Binns, M. M. 1988 Gene sequence and mapping data from Marek's disease virus and herpesvirus of turkeys: implications for herpesvirus classification. J. Gen. Virol. 69, 2033-2042.
16. Bulow, V. V. & Biggs, P. M. 1975a Differentiation between strains of Marek's disease virus and turkey herpesvirus by immunofluorescence assays. Avian Path. 4, 133-146.
17. Bulow, V. V. & Biggs, P. M. 1975b Precipitating antigens associated with Marek's disease viruses and a herpesvirus of turkeys. Avian Path. 4, 147-162.
18. Burkitt, D. P. 1969 Etiology of Burkitt's lymphomaan alternative hypothesis to a vectored virus. J. Natn. Cancer Inst. 42, 19-28.
19. Calnek, B. W. 1985 Genetic resistance. In Marek's disease - scientific basis and methods of control (ed. L. N. Payne), pp. 293-329. Boston, MA: Martinus Nijhoff.
20. Calnek, B. W. & Schat, K. A. 1978a Characterization of an apparently non-oncogenic Marek's disease virus. J. Natn. Cancer Inst. 60, 1075-1082.
21. Calnek, B. W. & Schat, K. A. 1978b Protection against Marek's disease-derived tumour transplants by the non-oncogenic SB1 strain of Marek's disease virus. Infect. Immun. 22, 225-232.
22. Calnek, B. W. & Witter, R. L. 1997 Marek's disease. In Disease of poultry, 10th edn (ed. B. W. Calnek), pp. 369-413. Ames, IO: Iowa State University Press.
23. Calnek, B. W., Adldinger, H. K. & Kahn, D. E. 1970a Feather follicle epithelium: a source of enveloped and infectious cell-free herpesvirus from Marek's disease. Avian Dis. 14, 219-233.
24. Calnek, B. W., Hitchner, S. B. & Adldinger, H. K. 1970b Lyophilization of cell-free Marek's disease herpesvirus and a herpesvirus from turkeys. Appl. Microbiol. 20, 723-726.
25. Calnek, B. W., Schat, K. A. & Fabricant, J. 1980 Modification of Marek's disease pathogenesis by in ovo infection or prior vaccination. In Viruses in naturally occurring cancers, vol. 7 (ed. M. Essex, G. Todaro & H. zur Hausen), pp. 185-197. New York: Cold Spring Harbor.
26. Cantello, J. L., Anderson, A. S. & Morgan, R. W. 1994 Identification of latency-associated transcripts that map antisense to the ICP4 homolog gene of Marek's disease virus. J. Virol. 68, 6280-6290.
27. Cebrian, J., Kaschka-Dierich, C., Berthelot, N. & Sheldrick, P. 1982 Inverted repeat nucleotide sequences in the genomes of Marek's disease virus and the herpesvirus of the turkey. Proc. Natn. Acad. Sci. USA 79, 555-558.
28. Chen, X. B., Sondermeijer, P. J. & Velicer, L. F. 1992 Identification of a unique Marek's disease virus gene which encodes a 38-kilodalton phosphoprotein and is expressed in both lytically infected cells and latently infected lymphoblastoid tumor cells. J. Virol. 66, 85-94.
29. Chubb, R. C. & Churchill, A. E. 1968 Effect of maternal antibody on Marek's disease. Vet. Rec. 85, 303-305.
30. Churchill, A. E., Chubb, R. C. & Baxendale, W. 1969a The attenuation, with loss of oncogenicity of the herpes-type virus of Marek's disease (strain HPRS-16) on passage in cell culture. J. Gen. Virol. 4, 557-464.
31. Churchill, A. E., Payne, L. N. & Chubb, R. C. 1969b Immunization against Marek's disease using a live attenuated virus. Nature 221, 744-747.
32. Cui, Z., Lee, L. F., Liu, J.-L. & Kung, H.-J. 1991 Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells. J. Virol. 65, 6509-6515.
33. Dandapat, S., Pradhan, H. K. & Mohanty, G. C. 1994 Anti-idiotype antibodies to Marek's disease-associated tumour surface antigen in protection against Marek's disease. Vet. Immunol. Immunopathol. 40, 353-366.
34. Else, R. W. 1974 Vaccinal immunity to Marek's disease in bursectomised chickens. Vet. Rec. 95, 182-187.
35. Fabricant, C. G., Fabricant, J., Litrenta, M. M. & Minick, C. R. 1978 Virus-induced atherosclerosis. J. Exp. Med. 148, 335-340.
36. Fukuchi, K., Tanaka, A., Schierman, L. W., Witter, R. L. & Nonoyama, M. 1985 The structure of Marek's disease virus DNA: the presence of unique expansion in nonpathogenic viral DNA. Proc. Natn. Acad. Sci. USA 82, 751-754.
37. Hlozanek, I., Mach, O. & Jurajda, V. 1973 Cell-free preparations of Marek's disease virus from poultry dust. Folia Biol. Praha 19, 118-123.
38. Hong, Y. & Coussens, P. M. 1994 Identification of an immediate early gene in the Marek's disease virus long internal repeat region which encodes a unique 14-kiloDalton polypeptide. J. Virol. 68, 3593-3603.
39. Hong, Y., Frame, M. & Coussens P. M. 1995 A 14-kDa immediate-early phosphoprotein is specifically expressed in cells infected with oncogenic Marek's disease virus strains and their attenuated derivatives. Virology 206, 695-700.
40. Jackson, C. A. W., Biggs, P. M., Bell, R. A., Lancaster, F. M. & Milne, B. S. 1974 A study of vaccination against Marek's disease with an attenuated Marek's disease virus. Avian Path. 3, 123-144.
41. Jackson, C. A. W., Biggs, P. M., Bell, R. A., Lancaster, F. M. & Milne, B. S. 1976 The epizootiology of Marek's disease. 3. The inter-relationship of virus pathogenicity, antibody and the incidence of disease. Avian Path. 5, 105-123.
42. Jones, D., Lee, L., Liu, J.-L., Kung, H.-J. & Tillotson, J. K. 1992 Marek's disease virus encodes a basic leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors. Proc. Natn. Acad. Sci. USA 89, 4042-4946.
43. Kawamura, M., Hayashi, M., Furuichi, T., Nonoyama, M., Isogai, E. & Namioka, S. 1991 The inhibitory effects of oligonucleotides, complementary to Marek's disease virus mRNA transcribed from the Bam H1-H region, on the proliferation of transformed lymphoblastoid cells, MDCC-MSB1. J. Gen. Virol. 72, 1105-1111.
44. Kitazawa, T., Ono, M., Maeda, K., Kawaguchi, Y., Kamiya, N., Niikura, M. & Mikami, T. 1993 Nucleotide sequence of glycoprotein C (gC) homologous gene of Marek's disease virus (MDV) serotype 2 and comparison of gC homologous genes among three serotypes of MDV. J. Vet. Med. Sci. 55, 985-990.
45. Kopacek, J., Ross, L. J. N., Zelnik, V. & Pastorek, J. 1993 The 132 bp repeats are present in RNA transcripts from 1.8 kb gene family of Marek's disease virus-transformed cells. Acta. Virol. 37, 191-195.
46. Kross, I. 1996 Isolation of highly lytic serotype l Marek's disease virus from recent field outbreaks in Europe. In Current research on Marek's disease: proc. 5th int. symp. on Marek's disease (ed. R. F. Silva, H. H. Chang, P. M. Coussens, L. F. Lee & L. F. Velicer), pp. 113-118. PA: American Association of Avian Pathologists.
47. Lesnik, F. & Ross, L. J. N. 1975 Immunization against Marek's disease using Marek's disease-specific antigens free from infectious virus. Int. J. Cancer 16, 153-163.
48. Li, D.-S., Pastorek, J., Zelník, V., Smith, G. D. & Ross, L. J. N. 1994 Identification of novel transcripts complementary to the Marek's disease virus homologue of the ICP4 gene of herpes simplex virus. J. Gen. Virol. 75, 1713-1722.
49. Liu, J.-L., Lee, L. F. & Kung, H.-J. 1996 Biological properties of the Marek's disease latent protein MEQ: subcellular localization and transforming potential. In Current research on Marek's disease: proc. 5th int. symp. on March's disease (ed. R. F. Silva, H. H. Chang, P. M. Coussens, L. F. Lee & L. F. Velicer), pp. 271-277. PA: American Association of Avian Pathologists.
50. McColl, K., Calnek, B. W., Harris, W. V., Schat, K. A. & Lee, L. F. 1987 Expression of a putative tumor-associated antigen on normal versus Marek's disease virus-transformed lymphocytes. J. Natn. Cancer Inst. 79, 991-1000.
51. McKinnell, R. G. & Ellis, V. L. 1972 Epidemiology of the frog renal tumour and the significance of tumour nuclear transplantation studies to a viral aetiology of the tumour - a review. In Oncogenesis and herpesviruses (ed. P. M. Biggs, G. de-Thé & L. N. Payne), pp. 183-197. Lyon: International Agency for Research on Cancer.
52. Maotani, K., Kanamori, A., Ikuta, K., Ueda, S., Kato, S. & Hirai, K. 1986 Amplification of a tandem direct repeat within inverted repeats of Marek's disease virus DNA during serial in vitro passage. J. Virol. 58, 657-660.
53. Marek, J. 1907 Multiple Nervenentzündung (polyneuritis) bei Hühnern. Dtsch. Tierarztl. Wochenschr. 15, 417-421.
54. Mason, R. J. & Jensen, K. E. 1971 Marek's disease: resistance of turkey herpesvirus-infected chicks against lethal JM-V agent. Am. J. Vet. Res. 32, 1625-1627.
55. Morgan, R., Anderson, A., Kent, J. & Parcells, M. 1996 Characterization of Marek's disease virus RB1B-based mutants having disrupted glycoprotein C or glycoprotein D homolog genes. In Current research on Marek's disease: proc. 5th int. symp. on March's disease (ed. R. F. Silva, H. H. Chang, P. M. Coussens, L. F. Lee & L. F. Velicer), pp. 207-212. PA: American Association of Avian Pathologists.
56. Murthy, K. K. & Calnek, B. W. 1979 Pathogenesis of Marek's disease: effect of immunization with inactivated viral and tumor-associated antigens. Infect. Immun. 26, 547-553.
57. Naito, M., Nakajima, K., Iwa, N., Ono, K., Yoshida, I., Konobe, T., Ikuta, K., Ueda, S., Kato, S. & Hirai, K. 1986 Demonstration of Marek's disease virus-specific antigen in tumour lesions of chickens with Marek's disease using monoclonal antibody against a virus phosphorylated protein. Avian Path. 15, 503-510.
58. Nakajima, K., Ikuta, K., Naito, M., Ueda, S., Kato, S. & Hirai, K. 1987 Analysis of Marek's disease virus serotype-1 specific phosphorylated polypeptides in virus-infected cells and Marek's disease lymphoblastoid cells. J. Gen. Virol. 68, 1379-1389.
59. Nazerian, K., Lee, L. F., Yanagida, N. & Ogawa, R. 1992 Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus. J. Virol. 66, 1409-1413.
60. Okazaki, W., Purchase, H. G. & Burmester, B. R. 1970 Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Dis. 14, 413-429.
61. Ono, K., Takashima, M., Ishikawa, T., Hayashi, M., Yoshida, I., Konobe, T., Ikuta, K., Nakajima, K., Ueda, S., Kato, S. & Hirai, K. 1985 Partial protection against Marek's disease in chickens immunized with glycoprotein gB purified from turkey-herpesvirus-infected cells by affinity chromatography coupled with monoclonal antibodies. Avian Dis. 29, 533-539.
62. Ono, M., Kawaguchi, Y., Maeda, K., Kamiya, M., Tohya, Y., Kai, C., Niikura, M. & Mikami, T. 1994 Nucleotide sequence analysis of Marek's disease virus (MDV) serotype-2 homolog of MDV serotype-1 pp38, an antigen associated with transformed cells. Virology 201, 142-146.
63. Ono, M., Maeda, K., Kawaguchi, Y., Kang, H. K., Tohya, Y., Niikura, M. & Mikami, T. 1995 Expression of Marek's disease virus (MDV) serotype-2 gene which has partial homology with MDV serotype-1 pp38 gene. Virus Res. 35, 223-239.
64. Pappenheimer, A. M., Dunn, L. C. & Cone, V. 1926 A study of fowl paralysis (neuro-lymphomatosis Gallinarum). Storrs Agricultural Experiment Station Dull. 143, 186-290.
65. Pappenheimer, A. M., Dunn, L. C. & Cone, V. 1929 Studies on fowl paralysis (neurolymphomatosis gallinarum). I. Clinical features and pathology. J. Exp. Med. 49, 63-86.
66. Parcells, M. S., Anderson, A. S. & Morgan, R. W. 1995 Retention of oncogenicity by a Marek's disease virus mutant lacking six unique short region genes. J. Virol. 69, 7888-7898.
67. Payne, L. N., Frazier, J. A. & Powell, P. C. 1976 Pathogenesis of Marek's disease. Int. Rev. Exp. Path. 16, 59-154.
68. Payne, L. N., Rennie, M. C., Powell, P. C. & Rowell, J. G. 1978 Transient effect of cyclophosphamide on vaccinal immunity to Marek's disease. Avian Path. 7, 295-304.
69. Peng, Q., Zeng, M., Bhuiyan, Z. A., Ubukata, E., Tanaka, A., Nonoyama, M. & Shirazi, Y. 1995 Isolation and characterization of Marek's disease virus (MDV) cDNA mapping to the BamH1-I2, BamH1-Q2, and BamH1-L fragments of the MDV genome from lymphoblastoid cells transformed and persistently infected with MDV. Virology 213, 590-599.
70. Powell, P. C. 1975 Immunity to Marek's disease induced by glutaraldehyde-treated cells of Marek's disease lymphoblastoid cell lines. Nature 257, 684-685.
71. Powell, P. C., Payne, L. N., Frazier, J. A. & Rennie, M. 1974 T-lymphoblastoid cell lines from Marek's disease lyinphomas. Nature 251, 79-80.
72. Purchase, H. G., Okazaka, W. & Burmcster, B. R. 1971 Field trials with the herpesvirus of turkeys (HVT) strain FC126 as a vaccine against Marek's disease. Poultry Sci. 50, 775-783.
73. Purchase, H. G. & Sharma, J. M. 1974 Amelioration of Marek's disease and absence of vaccine protection in immunologically deficient chickens. Nature 248, 419-421.
74. Qian, Z., Brunovskis, P., Rauscher III, F., Lee, L. & Kung, H.-J. 1995 Transactivation activity of meq, a Marek's disease herpesvirus bzip protein persistently expressed in latently infected transformed T-cells. J. Virol. 69, 4037-4044.
75. Rafferty Jr, K. A. 1972 Pathology of amphibian renal carcinoma - a review. In Oncogenesis and herpesviruses (ed. P. M. Biggs, G. de-Thé & L. N. Payne), pp. 159-170. Lyon: International Agency for Research on Cancer.
76. Ross, L. J. N. 1985 Molecular biology of the virus. In Marek's disease - scientific basis and methods of control (ed. L. N. Payne), pp. 113-150. Boston, MA: Martinus Nijhoff.
77. Ross, L. J. N. & Biggs, P. M. 1986 Vaccination against Marek's disease. In Leukaemia and lymphoma research. 3. Vaccine intervention against virus-induced tumours (ed. J. M. Goldman & M. A. Epstein), pp. 13-31. London: Macmillan.
78. Ross, L. J. N., Biggs, P. M. & Newton, A. A. 1973 Purification and properties of the 'A' antigen associated with Marek's disease virus infections. J. Gen. Virol. 18, 291-304.
79. Ross, L. J. N., Milne, B. & Biggs, P. M. 1983 Restriction endonuclease analysis of Marek's disease virus DNA and homology between strains. J. Gen. Virol. 64, 2785-2790.
80. Ross, N., Binns, M. M., Sanderson, M. & Schat, K. A. 1993a Alterations in DNA sequence and RNA transcription of the Bam H1-H fragment accompany attenuation of oncogenic Marek's disease herpesvirus. Virus Genes 7, 33-51.
81. Ross, L. J. N., Binns, M. M., Tyers, P., Pastorek, J., Zelnik, V. & Scott, S. 1993b Construction and properties of a turkey herpesvirus recombinant expressing the Marek's disease virus homologue of glycoprotein B of herpes simplex virus. J. Gen. Virol. 74, 371-377.
82. Ross, N., O'Sullivan, G., Baigent, S., Rennie, M., Rothwell, C. & Davison, F. 1995 Pathogenesis of Marek's disease: analysis of lymphoid tumours. Bull. Société Franco-Japonaise des Sciences Vétérinaires 6, 117-122.
83. Ross, N., O'Sullivan, G., Rothwell, C., Smith, G., Rennie, M., Lee, L. F. & Davison, T. F. 1996 Expression of MDV genes in lymphomas and their role in oncogenesis. In Current research on Marek's disease: proc. 5th int. symp. on Marek's disease (ed. R. F. Silva, H. H. Chang, P. M. Coussens, L. F. Lee & L. F. Velicer), pp. 40-46. PA: American Association of Avian Pathologists.
84. Schat, K. A. 1985 Characteristics of the virus. In Marek's disease - scientific basis and methods of control (ed. L. N. Payne), pp. 77-112. Boston, MA: Martinus Nijhoff.
85. Schat, K. A., Calnck, B. W., Fabricant, J. & Graham, D. L. 1985 Pathogenesis of infection with attenuated Marek's disease virus strains. Avion Path. 14, 127-140.
86. Schat, K. A., Chen, C.-L. H., Calnek, B. W. & Char, D. 1991 Transformation of T-lyrnphocyte subsets by Marek's disease herpesvirus. J. Virol. 65, 1408-1413.
87. Sevoian, M., Chamberlain, D. M. & Counter, M. S. 1962 Avian lymphomatosis - experimental reproduction of the neural and visceral form. Vet. Med. 57, 500-501.
88. Sharma, J. M., Witter, R. L. & Purchase, H. G. 1975 Absence of age resistance in neonatally thymectomised chickens as evidence for cell-mediated immune surveillance in Marek's disease. Nature 253, 477-479.
89. Smith, G. D., Zelnik, V. & Ross, L. J. N. 1995 Gene organization in herpesvirus of turkeys: identification of a novel open reading frame in the long unique region and a truncated homologue of pp38 in the internal repeat. Virology 207, 205-216.
90. Smith, M. W. & Calnek, B. W. 1974 High virulence Marek's disease virus infection in chickens previously infected with low-virulence virus. J. Natn. Cancer Inst. 52, 1595-1603.
91. van Zaane, D., Brinkhof, J. M. A., Westenbrink, F. & Gielkins, A. L. J. 1982 Molecular-biological characteriztion of Marek's disease virus. I. Identification of virus-specific polypeptides in infected cells. Virology 121, 116-132.
92. Venugopal, K., Bland, A. P., Ross, L. J. N. & Payne, L. N. 1996 Pathogenicity of an unusual highly virulent Marek's disease virus isolated in the United Kingdom. In Current research on Marek's disease: proc. 5th int. symp. on Marek's disease (ed. R. F. Silva, H. H. Chang, P. M. Coussens, L. F. Lee & L. F. Velicer), pp. 119-124. PA: American Association of Avian Pathologists.
93. Wilson, W. R., Southwick, R. A., Pulaski, J. T., Tieber, V. L., Hong, Y. & Coussens, P. M. 1994 Molecular analysis of the glycoprotein C-negative phenotype of attenuated Marek's disease virus. Virology 199, 393-402.
94. Witter, R. L. 1992 Influence of serotype and virus strain on synergism between Marek's disease vaccine viruses. Avian Path. 21, 601-614.
95. Witter, R. L. 1996 Evolution of virulence of Marek's disease virus: evidence for a novel pathotype. In Current research on Marek's disease: proc. 5th int. symp. on Marek's disease (ed. R. F. Silva, H. H. Chang, P. M. Coussens, L. F. Lee & L. F. Velicer), pp. 86-91. PA: American Association of Avian Pathologists.
96. Witter, R. L., Solomon, J. J., Champion, L. R. & Nazerian, K. 1971 Long term studies of Marek's disease infection in individual chickens. Avian Dis. 15, 346-365.
97. Witter, R. L., Sharma, J. M. & Fadly, A. M. 1980 Pathogenicity of variant Marek's disease virus isolants in vaccinated and unvaccinated chickens. Avian Dis. 24, 210-232.
98. Xie, Q., Anderson, A. S. & Morgan, R. W. 1996 Marek's disease virus (MDV) ICP4, pp38, and meq genes are involved in the maintenance of transformation of MDCC-MSB1 MDV-transformed lympoblastoid cells. J. Virol. 70, 1125-1131.
99. Zander, D. V., Hill, R. W., Raymond, R. G., Balch, R. K., Mitchell, R. W. & Dunsing, J. W. 1972 The use of blood from selected chickens as an immunizing agent for Marek's disease. Avian Dis. 16, 163-178.